|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 111, Issue 20 3035-3043, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
JY Choi, AJ van Wijnen, F Aslam, JD Leszyk, JL Stein, GS Stein, JB Lian and S Penman
Department of Cell Biology and Cancer Center, and Protein Chemistry Facility, University of Massachusetts Medical Center, Worcester, MA 01655, USA.
The protein composition of the nuclear matrix changes significantly as the osteoblast matures from a proliferating pre-osteoblast to an osteocyte embedded in a mineralized matrix. These matrix protein are the result of developmental stage-specific gene expression during osteoblast differentiation. To isolate nuclear matrix proteins unique to the bone phenotype we analyzed nuclear matrix preparations from cultures of rat calvarial osteoblasts by high resolution two-dimensional gel electrophoresis at two different stages: proliferation (day 3) and differentiation (day 18, mineralized). We characterized one protein (14 kDa; pI 5.0), that was detectable only in the nuclear matrix of differentiated osteoblasts. By mass spectrometry and microsequencing, this protein was identified as the beta -galactoside-binding protein galectin-1. Both immunofluorescence staining of nuclear matrix preparations with the galectin-1 antibody and western blot analysis of subcellular fractions confirmed that galectin-1 is only associated with the nuclear matrix in differentiated osteoblasts as the result of differential retention. Galectin-1 protein and mRNA are present throughout osteoblast differentiation. Galectin-1 is present in the cytoplasmic and nuclear fractions in both proliferating and differentiated osteoblasts. However, its only stable binding is to the nuclear matrix of the differentiated osteoblast; but, in proliferating osteoblasts, galectin-1 is not retained in the nuclear matrix. Taken together, our results suggest that developmental association of galectin-1 with the nuclear matrix reflects differential subnuclear binding of galectin-1 during osteoblast differentiation.
This article has been cited by other articles:
![]() |
F. Kantawong, R. Burchmore, N. Gadegaard, R. O. C. Oreffo, and M. J. Dalby Proteomic analysis of human osteoprogenitor response to disordered nanotopography J R Soc Interface, November 6, 2009; 6(40): 1075 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, J. W. Park, J. L. Wang, and R. J. Patterson Immunoprecipitation of spliceosomal RNAs by antisera to galectin-1 and galectin-3 Nucleic Acids Res., October 6, 2006; (2006) gkl673v3. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu, R. Siegel, and R. G. Roeder Interaction of the B Cell-specific Transcriptional Coactivator OCA-B and Galectin-1 and a Possible Role in Regulating BCR-mediated B Cell Proliferation J. Biol. Chem., June 2, 2006; 281(22): 15505 - 15516. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Park, Y.-K. Jung, O.-J. Park, Y. J. Lee, J.-Y. Choi, and Y. Choi Interaction of Fas Ligand and Fas Expressed on Osteoclast Precursors Increases Osteoclastogenesis J. Immunol., December 1, 2005; 175(11): 7193 - 7201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mitra, R.-L. Xie, R. Medina, H. Hovhannisyan, S. K. Zaidi, Y. Wei, J. W. Harper, J. L. Stein, A. J. van Wijnen, and G. S. Stein Identification of HiNF-P, a Key Activator of Cell Cycle-Controlled Histone H4 Genes at the Onset of S Phase Mol. Cell. Biol., November 15, 2003; 23(22): 8110 - 8123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. X. Luong, C. M. van der Meijden, D. Xing, R. Hesselton, E. S. Monuki, S. N. Jones, J. B. Lian, J. L. Stein, G. S. Stein, E. J. Neufeld, et al. Genetic Ablation of the CDP/Cux Protein C Terminus Results in Hair Cycle Defects and Reduced Male Fertility Mol. Cell. Biol., March 1, 2002; 22(5): 1424 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Javed, B Guo, S Hiebert, J. Choi, J Green, S. Zhao, M. Osborne, S Stifani, J. Stein, J. Lian, et al. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription J. Cell Sci., January 6, 2000; 113(12): 2221 - 2231. [Abstract] [PDF] |
||||